384 related articles for article (PubMed ID: 30794576)
1. Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
Maixnerova D; Ling C; Hall S; Reily C; Brown R; Neprasova M; Suchanek M; Honsova E; Zima T; Novak J; Tesar V
PLoS One; 2019; 14(2):e0212254. PubMed ID: 30794576
[TBL] [Abstract][Full Text] [Related]
2. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
Bagchi S; Lingaiah R; Mani K; Barwad A; Singh G; Balooni V; Bhowmik D; Agarwal SK
PLoS One; 2019; 14(3):e0214256. PubMed ID: 30917188
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H
Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
[TBL] [Abstract][Full Text] [Related]
5. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
6. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
Placzek WJ; Yanagawa H; Makita Y; Renfrow MB; Julian BA; Rizk DV; Suzuki Y; Novak J; Suzuki H
PLoS One; 2018; 13(1):e0190967. PubMed ID: 29324897
[TBL] [Abstract][Full Text] [Related]
7. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.
Yanagawa H; Suzuki H; Suzuki Y; Kiryluk K; Gharavi AG; Matsuoka K; Makita Y; Julian BA; Novak J; Tomino Y
PLoS One; 2014; 9(5):e98081. PubMed ID: 24858067
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
Camilla R; Suzuki H; Daprà V; Loiacono E; Peruzzi L; Amore A; Ghiggeri GM; Mazzucco G; Scolari F; Gharavi AG; Appel GB; Troyanov S; Novak J; Julian BA; Coppo R
Clin J Am Soc Nephrol; 2011 Aug; 6(8):1903-11. PubMed ID: 21784819
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.
Berthoux F; Suzuki H; Thibaudin L; Yanagawa H; Maillard N; Mariat C; Tomino Y; Julian BA; Novak J
J Am Soc Nephrol; 2012 Sep; 23(9):1579-87. PubMed ID: 22904352
[TBL] [Abstract][Full Text] [Related]
10. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation.
Berthoux F; Suzuki H; Mohey H; Maillard N; Mariat C; Novak J; Julian BA
J Am Soc Nephrol; 2017 Jun; 28(6):1943-1950. PubMed ID: 28255003
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Ohta K; Yachie A
J Immunol Res; 2020; 2020():4284379. PubMed ID: 32537466
[TBL] [Abstract][Full Text] [Related]
13. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
Moldoveanu Z; Suzuki H; Reily C; Satake K; Novak L; Xu N; Huang ZQ; Knoppova B; Khan A; Hall S; Yanagawa H; Brown R; Winstead CJ; O'Quinn DB; Weinmann A; Gharavi AG; Kiryluk K; Julian BA; Weaver CT; Suzuki Y; Novak J
J Autoimmun; 2021 Mar; 118():102593. PubMed ID: 33508637
[TBL] [Abstract][Full Text] [Related]
14. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression.
Zhao N; Hou P; Lv J; Moldoveanu Z; Li Y; Kiryluk K; Gharavi AG; Novak J; Zhang H
Kidney Int; 2012 Oct; 82(7):790-6. PubMed ID: 22673888
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
Zhang K; Li Q; Zhang Y; Shang W; Wei L; Li H; Gao S; Yan T; Jia J; Liu Y; Lin S
Kidney Blood Press Res; 2019; 44(5):1196-1206. PubMed ID: 31574506
[TBL] [Abstract][Full Text] [Related]
16. Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.
Zhang X; Xie X; Shi S; Liu L; Lv J; Zhang H
Nephrol Dial Transplant; 2020 Dec; 35(12):2117-2123. PubMed ID: 31377786
[TBL] [Abstract][Full Text] [Related]
17. TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy.
Zheng N; Xie K; Ye H; Dong Y; Wang B; Luo N; Fan J; Tan J; Chen W; Yu X
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32699192
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
[TBL] [Abstract][Full Text] [Related]
19. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
Yasutake J; Suzuki Y; Suzuki H; Hiura N; Yanagawa H; Makita Y; Kaneko E; Tomino Y
Nephrol Dial Transplant; 2015 Aug; 30(8):1315-21. PubMed ID: 26109484
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis.
Suzuki H
Clin Exp Nephrol; 2019 Jan; 23(1):26-31. PubMed ID: 29740706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]